Natco Permitted to Sell Spinal Muscular Atrophy Drug; Roche’s Patent Infringement Appeal Rejected: Delhi High Court
In a major pharmaceutical patent ruling, the Delhi High Court dismissed an appeal filed by Swiss drugmaker F. Hoffmann-La Roche AG against Natco Pharma Ltd, thereby upholding the refusal of an interim injunction in a patent dispute over Risdiplam, a life-saving drug used in the treatment of Spinal Muscular Atrophy (SMA). The decision was delivered by a Division Bench of Justice C Hari Shankar and Justice Ajay Digpaul in FAO(OS)…
